# Kreuzer_2013_Chronic tinnitus an interdisciplinary challenge.

M E D I C I N E

REVIEW ARTICLE

Chronic Tinnitus:  
an Interdisciplinary Challenge

Peter M. Kreuzer, Veronika Vielsmeier, Berthold Langguth

SUMMARY
Background: Tinnitus is defined as the perception of sound 
in the absence of a corresponding external acoustic 
stimulus. It is a common problem that markedly impairs 
the quality of life of about 1% of the general population. 

Methods: We selectively reviewed the pertinent literature 
to provide an overview of the current treatment options for 
chronic tinnitus.

Results: Cognitive behavioral therapy is effective and is 
the best studied of all currently available treatments. All 
patients should have a therapeutic interview for counsel-
ing. Auditory stimulation can also lessen tinnitus: It is used 
in tinnitus maskers and hearing aids, as well as in tinnitus 
retraining therapy. An improved understanding of the 
 neural mechanisms of tinnitus has led to the development 
of innovative techniques of neuromodulation and neuro -
stimulation, but these are still experimental. Drugs are 
 indicated only for the treatment of tinnitus-associated 
symptoms such as depression, sleep disturbances, and 
anxiety. 

Conclusion: There are many ways to treat chronic tinnitus, 
and new treatments are now being developed. As tinnitus 
has many causes and can be associated with many differ-
ent comorbid disturbances, multidisciplinary diagnostic 
evaluation and treatment are important. For many tinnitus 
patients, long-term therapeutic success depends on the 
maintenance of a therapeutic relationship with the treat-
ing physician, so that the physician and the patient can 
work together to give careful consideration to each newly 
proposed diagnostic test or treatment step.

►Cite this as: 

 Kreuzer PM, Vielsmeier V, Langguth B:  
Chronic tinnitus: an interdisciplinary challenge.  
Dtsch Arztebl Int 2013; 110(16): 278–84.  
DOI: 10.3238/arztebl.2013.0278

Department of Psychiatry and Psychotherapy, University of Regensburg:  
Dr. med. Kreuzer, PD Dr. med. Langguth

Department of Otorhinolaryngology, University Hospital of Regensburg: 
 Dr. med. Vielsmeier

Tinnitus Centre, University Hospital of Regensburg:  
Dr. med. Kreuzer, Dr. med. Vielsmeier, PD Dr. med. Langguth

278 

T he term “tinnitus” (from the Latin tinnire, to ring) 

describes a disorder in which noises are heard in 
the absence of corresponding external acoustic stimuli. 
Most experts distinguish between subjective and objec-
tive  tinnitus  (1).  Objective  tinnitus  is  a  condition  in 
which noises are generated within the body and trans-
mitted to the ear, e.g., via spasms of the tensor muscle 
of  the  tympanic  membrane.  Objective  tinnitus  is  rare 
and generally amenable to causally oriented treatment 
(1). Subjective tinnitus, like acoustic hallucinations, is 
a phantom phenomenon. Acoustic hallucinations occur 
particularly  in  patients  with  schizophrenia  or  after 
 consumption of hallucinogenic substances and tend to 
involve  the  perception  of  sounds  in  organized  form, 
such  as  music  or  speech. Tinnitus,  on  the  other  hand, 
consists of unorganized acoustic impressions of various 
kinds.  The  ear  noise  may  be  perceived  as  unilateral, 
 bilateral, or arising in the head.

Epidemiology
Between 5% and 15% of the general population report 
tinnitus  (2),  and  around  1%  state  that  their  quality  of 
life  is  considerably  impaired  by  their  ear  noises  (3). 
This divergence between high overall prevalence and a 
relatively  low  proportion  of  tinnitus  sufferers  with 
 severe problems may result from habituation, but may 
also be attributable to a relatively low degree of bother 
from  the  outset  (e1).  In  addition,  accompanying 
 diseases such as sleep disorders, depression, or anxiety 
disorders  can  have  negative  effects  on  almost  all 
 aspects of daily life (4, 5).

Problems in dealing with tinnitus
Many  physicians  feel  helpless  in  the  face  of  tinnitus 
(6), and this frequently leads to therapeutic nihilism (7). 
Some tinnitus patients report that the worst moment of 
their individual disease history was not the onset of the 
ear  noises,  but  rather  when  the  treating  physician  in-
formed them that there was “nothing more to be done” 
and that they would “just have to live with it.”

In actual fact there are many different treatment ap-
proaches, some of which can be readily integrated into 
daily clinical practice. Our intention with this article is 
to  provide  a  practice-related  treatment  guideline  for 
dealing  with  tinnitus  patients,  to  review  the  currently 

Deutsches Ärzteblatt International | Dtsch Arztebl Int 2013; 110(16): 278−84

available  evidence-based  treatment  options,  and,  not 
least,  to  assess  their  clinical  efficacy.  To  that  end  we 
carried  out  a  selective  review  of  the  literature  in  the 
PubMed database (search term: “chronic tinnitus”). We 
also evaluated relevant book chapters and took account 
of our own clinical experience.

FIGURE 1

Dorsolateral 
prefrontal cortex

Auditory 
cortex

Pathophysiology
For many years tinnitus was understood as an inner ear 
disease.  Under  the  misapprehension  that  the  noises 
were generated in the inner ear, some patients had their 
acoustic nerve transected. However, this generally did 
not  lead  to  cessation  of  the  phantom  phenomena  (8), 
which underlines the crucial importance of the central 
nervous  system  for  the  pathophysiology  of  chronic 
 tinnitus  (8).  We  now  know  that  tinnitus  involves 
 augmented  stimulation  all  the  way  along  the  central 
auditory  pathway  which—similarly 
to  phantom 
pain—arises as a compensatory reaction to  the partial 
hearing loss experienced in most cases (9–11). Abnor-
mal activity in somatosensory afferent nerves can also 
lead to increased activity in the central auditory path-
way (e2–e4). This explains the clinical observation that 
symptoms in the cervical spine or temporomandibular 
joint may play a part in the origin of tinnitus (12, e5, 
e6).

However,  the  functional  changes  in  patients  with 
chronic tinnitus are not restricted to auditory structures, 
but extend to limbic, parietal, and frontal regions (13, 
e7, e8). The functional connection of these areas to the 
auditory  cortex  is  more  intensive  in  tinnitus  patients 
than  in  healthy  persons  (13,  14).  The  mental  stress 
 associated with tinnitus is reflected by the coactivation 
of  an  unspecific  distress  network  which  includes, 
among other structures, the anterior cingulum, anterior 
insula,  and  amygdala. Apart  from  its  role  in  tinnitus, 
this  network  plays  a  part  in  pain  syndromes  and 
 somatoform disorders (e9) (Figure 1).

Case history and diagnostic work-up
In every case of tinnitus the following features must be 
determined:

● Duration of the tinnitus (acute versus chronic)
● Pulsatility
● Modulability of the tinnitus
● Attendant symptoms such as sleep disorders and 

concentration problems

investigation  of 

Every  patient  should  undergo  ENT  examination, 
 audiological 
their  hearing,  and 
 determination of the frequency and volume of the ear 
noise. Tinnitus  synchronized  with  the  pulse  may  be  a 
symptom  of  vascular  malformations  (vascular  loops, 
aneurysms,  etc.),  and  patients  in  whom  it  is  found 
should  be  referred  for  neuroradiological  examination. 
Magnetic  resonance  imaging  to  exclude  a  vestibular 
schwannoma  is  recommended  in  patients  with  unilat-
eral  tinnitus  and  a  distinct  right–left  discrepancy  in 
hearing  acuity.  In  cases  where  the  ear  noise  can  be 
modulated by movements of the jaw or cervical spine, 
physiotherapy or examination by an orthopedist/ortho-

Deutsches Ärzteblatt International | Dtsch Arztebl Int 2013; 110(16): 278−84 

Inferior 
parietal 
cortex

Amygdala

Hippocampus 

Neuronal networks in chronic tinnitus
Besides altered activity in the auditory system, patients with chronic 
tinnitus exhibit changes in brain areas with responsibility for affect 
regulation (amygdala, hippocampus, etc.) and in frontoparietal 
 regions relevant for regulation of attention and for conscious 
 perception. Source: MEGANIM/Gehirn&Geist, reproduced by kind 
permission of MEGANIM Medical Graphics and Animation, 
 Heidelberg, Germany

dontist should be considered. Validated questionnaires 
are available for assessment of the subjective severity 
of  tinnitus  (15)  (for  further  detail  see  Figure  2  and 
Box).

Treatment indications
The  individual  degree  of  bother  is  crucial  in  deciding 
whether  symptomatic  treatment  is  indicated,  to  avoid 
pathologizing the ear noise in patients whose quality of 
life is not impaired to any great extent. It often seems 
helpful to mention the trials that have shown that even 
people  without  tinnitus  tend  to  experience  phantom 
noises  in  particular  situations  (e.g.,  complete  auditory 
deprivation 
in  a  soundproof  booth)  (16).  Many 
 patients  are  relieved  simply  to  be  told  that  their  ear 
noise  is   benign  in  nature  and  that  most  patients 
 habituate  over  time,  so  often  no  further  treatment  is 
required.

Attendant symptoms
The degree to which patients suffer from their tinnitus 
shows pronounced interindividual variation that cannot 
be explained by the characteristics of the ear noise (vol-
ume,  frequency,  etc.)  (17).  The  considerable  differ-
ences  in  burden  of  suffering  often  seem  more  closely 
linked  to  the  varying  severity  of  accompanying 
 symptoms  such  as  sleep  disorders  and  concentration 
problems.

Patients whose tinnitus is accompanied by misopho-
nia  (perception  of  specific  noises  as  unpleasant), 
 phonophobia  (fear  of  specific  noises),  or  hyperacusis 
(perception  of  all  sounds  as  louder)  are  particularly 

M E D I C I N E

279

M E D I C I N E

FIGURE 2

"(cid:14)(cid:10)(cid:20)(cid:3)(cid:27)(cid:15)(cid:10)(cid:13)(cid:8)(cid:21)(cid:28)
(cid:6)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)(cid:3)(cid:30)(cid:11)(cid:20)(cid:10)(cid:13)(cid:15)(cid:8)(cid:9)(cid:9)(cid:14)(cid:15)(cid:21)(cid:20)

+ 

Clinical examination
(cid:2)(cid:3)(cid:3)(cid:4)(cid:5)(cid:6)(cid:3)(cid:7)(cid:8)(cid:9)(cid:10)(cid:11)(cid:12)(cid:13)(cid:14)(cid:13)(cid:15)(cid:8)(cid:9)
(cid:2)(cid:3)(cid:3)(cid:16)(cid:11)(cid:10)(cid:7)(cid:11)(cid:12)(cid:13)(cid:14)(cid:13)(cid:15)(cid:8)(cid:9)
(cid:2)(cid:3)(cid:3)(cid:4)(cid:17)(cid:14)(cid:18)(cid:15)(cid:9)(cid:14)(cid:13)(cid:15)(cid:8)(cid:9)(cid:3)(cid:8)(cid:19)(cid:3)(cid:7)(cid:20)(cid:21)(cid:22)(cid:15)(cid:7)(cid:14)(cid:12)(cid:3)
   spine and temporomandibular 
   joint

+ 

(cid:16)(cid:11)(cid:23)(cid:15)(cid:8)(cid:12)(cid:8)(cid:24)(cid:15)(cid:7)(cid:14)(cid:12)(cid:3)(cid:15)(cid:9)(cid:22)(cid:20)(cid:10)(cid:13)(cid:15)(cid:24)(cid:14)(cid:13)(cid:15)(cid:8)(cid:9)
(cid:2)(cid:3) (cid:6)(cid:8)(cid:9)(cid:20)(cid:25)(cid:10)(cid:26)(cid:20)(cid:20)(cid:7)(cid:27)(cid:3)(cid:14)(cid:11)(cid:23)(cid:15)(cid:8)(cid:18)(cid:20)(cid:13)(cid:21)(cid:28)
(cid:2)(cid:3)(cid:3)(cid:29)(cid:20)(cid:13)(cid:20)(cid:21)(cid:18)(cid:15)(cid:9)(cid:14)(cid:13)(cid:15)(cid:8)(cid:9)(cid:3)(cid:8)(cid:19)(cid:3)(cid:13)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)(cid:3)
(cid:3)(cid:3)(cid:3)(cid:19)(cid:21)(cid:20)(cid:30)(cid:11)(cid:20)(cid:9)(cid:7)(cid:28)(cid:3)(cid:14)(cid:9)(cid:23)(cid:3)(cid:12)(cid:8)(cid:11)(cid:23)(cid:9)(cid:20)(cid:10)(cid:10)
(cid:2)(cid:3)(cid:3)(cid:31)(cid:15)(cid:9)(cid:15)(cid:18)(cid:14)(cid:12)(cid:3)(cid:18)(cid:14)(cid:10)!(cid:15)(cid:9)(cid:24)(cid:3)(cid:12)(cid:20)(cid:22)(cid:20)(cid:12)
(cid:2)(cid:3)(cid:3)(cid:6)(cid:28)(cid:18)(cid:26)(cid:14)(cid:9)(cid:8)(cid:18)(cid:20)(cid:13)(cid:21)(cid:28)

(cid:2)(cid:3)(cid:3)#(cid:8)(cid:13)(cid:27)(cid:20)(cid:21)(cid:10)(cid:8)(cid:18)(cid:20)(cid:3)(cid:13)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)$
(cid:2)(cid:3)(cid:3)(cid:16)(cid:7)(cid:11)(cid:13)(cid:20)(cid:3)(cid:13)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)(cid:3)%(cid:15)(cid:13)(cid:27)(cid:3)(cid:27)(cid:20)(cid:14)(cid:21)(cid:15)(cid:9)(cid:24)(cid:3)(cid:12)(cid:8)(cid:10)(cid:10)$
(cid:2)(cid:3)(cid:3)&(cid:8)(cid:10)(cid:13)’(cid:13)(cid:21)(cid:14)(cid:11)(cid:18)(cid:14)(cid:13)(cid:15)(cid:7)(cid:3)(cid:13)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)$
(cid:2)(cid:3)(cid:3)(cid:16)(cid:7)(cid:11)(cid:13)(cid:20)(cid:3)(cid:26)(cid:11)(cid:12)(cid:10)(cid:14)(cid:13)(cid:15)(cid:12)(cid:20)(cid:3)(cid:13)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)$

If none 
(cid:8)(cid:19)(cid:3)(cid:13)(cid:27)(cid:20)(cid:10)(cid:20)(cid:3)
(cid:14)(cid:26)(cid:26)(cid:12)(cid:28)

(cid:5)(cid:8)(cid:3)(cid:19)(cid:11)(cid:21)(cid:13)(cid:27)(cid:20)(cid:21)(cid:3)
measures 
(cid:9)(cid:20)(cid:7)(cid:20)(cid:10)(cid:10)(cid:14)(cid:21)(cid:28)

((cid:19)(cid:3)(cid:8)(cid:9)(cid:20)(cid:3)(cid:8)(cid:19)(cid:3)(cid:13)(cid:27)(cid:20)(cid:10)(cid:20)(cid:3)(cid:14)(cid:26)(cid:26)(cid:12)(cid:15)(cid:20)(cid:10)

Nonpulsatile tinnitus

Pulsatile tinnitus

(cid:16)(cid:7)(cid:11)(cid:13)(cid:20)(cid:3)
tinnitus 
%(cid:15)(cid:13)(cid:27)(cid:3)(cid:14)(cid:7)(cid:11)(cid:13)(cid:20)(cid:3)
(cid:27)(cid:20)(cid:14)(cid:21)(cid:15)(cid:9)(cid:24)(cid:3)(cid:12)(cid:8)(cid:10)(cid:10)

(cid:6)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)(cid:3)%(cid:15)(cid:13)(cid:27)(cid:3)
(cid:27)(cid:20)(cid:14)(cid:21)(cid:15)(cid:9)(cid:24)(cid:3)
impairment

(cid:6)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)(cid:3)
%(cid:15)(cid:13)(cid:27)(cid:3)
vertigo

(cid:6)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)(cid:3)
%(cid:15)(cid:13)(cid:27)(cid:3)
(cid:27)(cid:20)(cid:14)(cid:23)(cid:14)(cid:7)(cid:27)(cid:20)

(cid:6)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)(cid:3)%(cid:15)(cid:13)(cid:27)(cid:3)
(cid:26)(cid:10)(cid:28)(cid:7)(cid:27)(cid:15)(cid:14)(cid:13)(cid:21)(cid:15)(cid:7)(cid:3)
(cid:7)(cid:8)(cid:18)(cid:8)(cid:21))(cid:15)(cid:23)(cid:15)(cid:13)(cid:28)

(cid:6)(cid:15)(cid:9)(cid:9)(cid:15)(cid:13)(cid:11)(cid:10)(cid:3)%(cid:15)(cid:13)(cid:27)(cid:3)
(cid:10)(cid:8)(cid:18)(cid:14)(cid:13)(cid:8)’
(cid:10)(cid:20)(cid:9)(cid:10)(cid:8)(cid:21)(cid:28)(cid:3)
(cid:7)(cid:8)(cid:18)(cid:8)(cid:21))(cid:15)(cid:23)(cid:15)(cid:13)(cid:28)

&(cid:8)(cid:10)(cid:13)’
traumatic 
tinnitus

Vestibular
diagnosis

(cid:29)(cid:15)(cid:19)(cid:19)(cid:20)(cid:21)(cid:20)(cid:9)(cid:13)(cid:15)(cid:14)(cid:12)(cid:3)
diagnosis 
(cid:8)(cid:19)(cid:3)(cid:27)(cid:20)(cid:14)(cid:23)(cid:14)(cid:7)(cid:27)(cid:20)

(cid:29)(cid:15)(cid:19)(cid:19)(cid:20)(cid:21)(cid:20)(cid:9)(cid:13)(cid:15)(cid:14)(cid:12)(cid:3)
diagnosis

Functional 
diagnosis 
cervical 
(cid:10)(cid:26)(cid:15)(cid:9)(cid:20)(cid:25)*(cid:14)%

(cid:29)(cid:15)(cid:19)(cid:19)(cid:20)(cid:21)(cid:20)(cid:9)(cid:13)(cid:15)(cid:14)(cid:12)(cid:3)
diagnosis

Neurovascular/
cardiac/internal 
medical 
diagnosis

&(cid:21)(cid:15)(cid:18)(cid:14)(cid:21)(cid:28)(cid:3)
treatment 
of acute 
(cid:27)(cid:20)(cid:14)(cid:21)(cid:15)(cid:9)(cid:24)(cid:3)(cid:12)(cid:8)(cid:10)(cid:10)

(cid:6)(cid:21)(cid:20)(cid:14)(cid:13)(cid:18)(cid:20)(cid:9)(cid:13)(cid:3)(cid:8)(cid:19)(cid:3)
(cid:27)(cid:20)(cid:14)(cid:21)(cid:15)(cid:9)(cid:24)(cid:3)(cid:12)(cid:8)(cid:10)(cid:10)(cid:3)
%(cid:15)(cid:13)(cid:27)(cid:3)
(cid:27)(cid:20)(cid:14)(cid:21)(cid:15)(cid:9)(cid:24)(cid:3)(cid:14)(cid:15)(cid:23)0(cid:3)
(cid:7)(cid:8)(cid:7)(cid:27)(cid:12)(cid:20)(cid:14)(cid:21)(cid:3)
implant, …

Specific 
treatment, 
e.g., for 
(cid:31)(cid:20)(cid:9)(cid:15)+(cid:21)(cid:20)-(cid:10)(cid:3)
disease

Specific 
treatment 
if possible

Specific 
treatment of 
(cid:26)(cid:10)(cid:28)(cid:7)(cid:27)(cid:15)(cid:14)(cid:13)(cid:21)(cid:15)(cid:7)(cid:3)
(cid:7)(cid:8)(cid:18)(cid:8)(cid:21))(cid:15)(cid:23)(cid:15)(cid:13)(cid:28)

Specific 
treatment

Specific 
treatment of 
consequences
of trauma

Specific 
treatment of 
vascular disease

((cid:19)(cid:3)(cid:7)(cid:14)(cid:11)(cid:10)(cid:14)(cid:12)(cid:12)(cid:28)(cid:3)(cid:8)(cid:21)(cid:15)(cid:20)(cid:9)(cid:13)(cid:20)(cid:23)(cid:3)(cid:13)(cid:21)(cid:20)(cid:14)(cid:13)(cid:18)(cid:20)(cid:9)(cid:13)(cid:3)(cid:15)(cid:10)(cid:3)(cid:15)(cid:18)(cid:26)(cid:8)(cid:10)(cid:10)(cid:15))(cid:12)(cid:20)(cid:3)(cid:8)(cid:21)(cid:3)(cid:11)(cid:9)(cid:10)(cid:14)(cid:13)(cid:15)(cid:10)(cid:19)(cid:14)(cid:7)(cid:13)(cid:8)(cid:21)(cid:28)

#(cid:20)(cid:27)(cid:14)(cid:22)(cid:15)(cid:8)(cid:21)(cid:14)(cid:12)(cid:3)(cid:13)(cid:27)(cid:20)(cid:21)(cid:14)(cid:26)(cid:28)

Neuromodulation/neurostimulation

Tinnitus: from initial findings to treatment
Evidence-based diagnostic and therapeutic algorithm (modified from www.tinnitusresearch.org/en/projects/flowchart_en.php and [e29]).  
The empirical basis is stronger for behavioral therapy than for neuromodulation/neurostimulation

BOX

Clinical classification of the severity of tinnitus
Classification of the severity of tinnitus according to Biesinger et al. (e30) is constructed along clinical and practical lines and 
takes account of the occupational and social effects of the ear noise.

Grade 1: The tinnitus is well compensated; the patient does not think of him- or herself as ill.
Grade 2: The tinnitus occurs mainly in quiet surroundings and is bothersome when the patient is stressed.
Grade 3: The tinnitus causes lasting impairments in the patient’s private life and at work. Emotional, cognitive and physical 

problems ensue.

Grade 4: The tinnitus leads to complete decompensation in the patient’s private life and to occupational disability. 

280 

Deutsches Ärzteblatt International | Dtsch Arztebl Int 2013; 110(16): 278−84

likely  to  display  avoidance  behavior  and  may  even 
 develop  a  full-blown  anxiety  disorder.  Avoidance 
 behavior  in  the  sense  of  blocking  out  noise  from  the 
normal  environment  is  thus  counterproductive  for 
 tinnitus  patients  and  may  reinforce  the  disease  in  that 
the central auditory system becomes further sensitized 
(16, 18).

Knowledge base
There currently exists no valid objective measure of the 
presence  of  tinnitus  or  the  effects  of  potential  treat-
ments. The methodological quality of treatment trials is 
heterogeneous  in  the  extreme,  as  emphasized  in  all 
available  Cochrane  meta-analyses 
touch  on 
 tinnitus (19–25). Accordingly, efforts are being made to 
improve quality standards in clinical trials of the treat-
ment of tinnitus (25–28).

that 

The  evidence  for  most  existing  treatments  for 
 tinnitus  is  limited.  Many  treatment  trials  have  shown 
positive  effects  for  individual  patients  but  not  for  the 
collective  as  a  whole.  To  some  extent  this  seems 
 attributable  to  the  heterogeneity  of  the  syndrome  of 
 tinnitus. It is assumed that the generic term “tinnitus” 
embraces  various  clinically  and  pathophysiologically 
distinct subtypes that respond in different ways to dif-
ferent forms of treatment (e10).

in 

some 

cases 

leading 

Treatment options
Psychoeducation/counseling
The picture conveyed to many tinnitus sufferers is one 
of  hopelessness, 
to 
 predominantly  negative  disease  models  and  coping 
strategies (e11). Psychoeducative counseling is recom-
mended  as  a  basic  component  of  every  treatment  for 
tinnitus  (e12,  e13).  In  our  personal  experience, 
 sympathetic  and  understandable  explanation  of  the 
 fundamentally  benign  nature  of  idiopathic  tinnitus  is 
often  all  that  is  needed.  Such  a  conversation  between 
physician and  patient represents the basis for establish-
ment  of  constructive  compensation  and  habituation 
mechanisms.

Cognitive behavioral therapy
Cognitive  behavioral  therapy  (CBT)  is  the  best-
 evaluated  treatment  for  tinnitus.  The  general  aim  of 
CBT in patients with tinnitus is to improve awareness 
and facilitate the modification of maladaptive patterns 
on  the  cognitive,  emotional,  and  behavioral  level.  A 
Cochrane  meta-analysis  of  eight  controlled  clinical 
trials with a total of 468 participants showed that CBT 
produced  significantly  better  results  than  the  control 
conditions of “no treatment” and “other interventions” 
(e.g.  short-term  psychoeducation)  with  regard  to 
quality of life (effect strength of standardized mean dif-
ference [SMD] between 0.64 and 0.91) and the depress-
ion score (SMD 0.37 compared with waiting list), but 
had no superior effect on ear noise volume (SMD 0.1) 
(22).  The  efficacy  of 
inpatient  psychotherapy, 
 widespread in Germany, has not yet been evaluated in 
randomized controlled trials.

Deutsches Ärzteblatt International | Dtsch Arztebl Int 2013; 110(16): 278−84 

Individualized auditory stimulation
Most tinnitus patients are particularly bothered by their 
ear  noise  in  quiet  surroundings.  Many  sufferers  find 
that targeted auditory stimulation reduces their tinnitus, 
and  this  is  one  of  the  frequently  employed  treatments 
(29).

Tinnitus  maskers—Tinnitus  maskers  generate 
either sounds from the natural environment or individ-
ually tailored noises. Despite the widespread use of ma-
sking procedures, only limited data are available from 
controlled  trials  (19,  30).  According  to  a  Cochrane 
meta-analysis,  the  efficacy  of  tinnitus  masking  has 
been neither clearly proved nor disproved (19). Thus it 
remains unclear whether complete or partial masking of 
tinnitus is more effective in the longer term (e14). Our 
practical  recommendation  is  therefore  that  patients 
should use whatever masking strategies they personally 
find  acceptable.  Dedicated  devices  are  commercially 
available, but more economical alternatives such as in-
door  fountains  or  recordings  of  waves  breaking  can 
also be used.

Hearing aid—Hearing aids are used to compensate 
for  hearing  loss  by  improving  the  peripheral  auditory 
input in the affected range of frequencies. To date, the 
influence of hearing aids on the perception of tinnitus 
has  not  been  demonstrated  in  randomized  controlled 
trials (30, e15). Observational studies suggest that par-
ticularly patients whose tinnitus frequency lies under 6 
kHz benefit from using a hearing aid (e16). If the tinni-
tus is associated  with severe  loss of hearing, cochlear 
implants  may  be  highly  effective  in  individual  cases 
(31, e17, e18).

Auditory  training—Various  forms  of  auditory 
training  have  been  investigated  in  tinnitus  patients, 
 including frequency discrimination training (e19, e20), 
intensity discrimination training (e21), and training in 
object  identification  and  localization  (e22).  However, 
their  efficacy  has  not  yet  been  confirmed 
in 
 high-quality randomized controlled trials (30, e21).

retraining 

Tinnitus retraining therapy
Tinnitus 
(TRT)  comprises  a 
therapy 
 combination of counseling and auditory stimulation by 
maskers  or  hearing  aids.  Three  studies  have 
 demonstrated positive effects of this treatment (32, e23, 
e24),  but  there  are  no  high-quality  controlled  trials;  a 
recent Cochrane meta-analysis therefore states that the 
clinical efficacy of TRT cannot be viewed as unequivo-
cally confirmed (23).

Neuromodulatory treatment
Based on the finding that chronic tinnitus results from 
or  at  least  goes  hand  in  hand  with  changes  in  central 
nervous  activity,  various  types  of  neuromodulatory 
treatment  for  tinnitus  have  been  developed  in  recent 
years.

Neurobiofeedback—Pilot  studies  on  the  use  of 
neurobiofeedback 
tinnitus  have  shown 
treat 
 significant  reductions  in  the  intensity  and  loudness  of 
ear  noise  (33,  e25,  e26).  Detailed  evaluation  of  the 

to 

M E D I C I N E

281

M E D I C I N E

clinical  efficacy  of  such  procedures 
 randomized controlled trials has yet to take place.

in 

large 

Repetitive 

transcranial  magnetic 

stimu-
lation—Repetitive  transcranial  magnetic  stimulation 
(rTMS) is a procedure in which magnetic impulses are 
used  to  modulate  the  activity  of  superficially  located 
brain  regions.  Several  randomized  controlled  trials 
have found evidence for clinical efficacy of rTMS (34). 
However, the effects of rTMS are slight, the interindi-
vidual variability is pronounced, and the duration of the 
treatment effect is often limited (23, 25).

thus  compensating 

Auditory  stimulation—Specific  forms  of  auditory 
stimulation have also been developed for the treatment 
of tinnitus. One suggestion is to modify the frequency 
spectrum of music according to the individual patient's 
audiometric  profile, 
the 
 individual  hearing  impairment  (36).  In  other  auditory 
stimulation  procedures,  precisely  the  frequencies  in 
which the tinnitus tone is localized are removed from 
the  frequency  spectrum  (“tailor-made  notched  music 
training”). In a pilot study in a small group of patients, 
daily  stimulation  outside  the  tinnitus  spectrum  for  a 
period  of  a  year  showed  a  significant  reduction  in 
ear  noise  volume  compared  with  a  control  condition 
(37).

for 

Coordinated reset stimulation—In another form of 
auditory stimulation, known as coordinated reset stimu-
lation,  the  patient  is  presented  with  short  tones  above 
and below his/her individual tinnitus frequency. An in-
itial pilot study has shown promising results (38), but 
further evaluation in larger groups of patients has yet to 
take place.

Despite  the  promising  pilot  data,  all  of  these 
 neuromodulatory  approaches 
treatment  of 
 tinnitus  must  be  regarded  as  experimental.  No  large, 
multicenter,  randomized  double-blind  trials  have  yet 
been conducted.

the 

to 

Pharmacotherapy
The observation that intravenous administration of the 
tension-dependent  sodium-channel  blocker  lidocaine 
led to temporary suppression of tinnitus in a majority of 
patients (e27, e28) suggests that tinnitus is amenable to 
pharmacological treatment in principle. The therapeutic 
use  of  lidocaine  is  limited,  however,  by  the  transient 
 nature  of  its  action  and  by  the  adverse  effects  of  the 
 intravenous route of administration.

Despite  the  investigation  of  a  large  number  of 
 pharmaceuticals, no medicinal approach can yet be re-
garded as an established treatment option. Accordingly, 
neither in Europe nor in the USA has any drug yet been 
approved  for  the  treatment  of  tinnitus  (39).  The  indi-
cation for pharmacotherapy is therefore restricted to the 
treatment  of  comorbidities  such  as  anxiety  disorders, 
sleep disorders, and depression.

Interdisciplinary approach to diagnosis and treatment
A  stepwise  multidisciplinary  treatment  program  con-
sisting  essentially  of  counseling,  behavioral  therapy, 
and  auditory  stimulation  was  recently  evaluated  in  a 

282 

large randomized controlled trial (40). Compared with 
standard  treatment  over  an  observation  period  of  12 
months, 
treatment 
the  stepwise  multidisciplinary 
 program showed significant improvements in
life 

strength  d = 0.24; 

(effect 

● quality  of 
p = 0.0009),

● severity of tinnitus (d = 0.43; p = 0.0001),
● degree of disability caused by tinnitus (d = 0.45; 

p<0.0001).

The  specialized  treatment  program  started  with 
 audiological  measurements/treatment  and  counseling, 
followed  by  optional  multidisciplinary  group  or 
 individual treatment sessions for a period of 12 weeks. 
These  sessions  involved  clinical  psychologists,  exer-
cise  therapists,  physiotherapists,  audiologists,  social 
workers, and speech therapists. The results of this study 
underline 
interdisciplinary, 
importance  of  an 
 stepwise approach to the treatment of tinnitus.

the 

Summary
The  management  of  chronic 
tinnitus  remains  a 
 challenge  despite  the  availability  of  various  forms  of 
treatment,  but  there  is  no  justification  for  therapeutic 
nihilism. No doctor today should say “there’s nothing 
we can do.” Cooperation among various disciplines is 
vital in the diagnosis and treatment of tinnitus.

It  is  also  crucial  for  patients  with  chronic  tinnitus 
whether  the  physician  directly  responsible  for  their 
treatment reacts to their description of their symptoms 
with patent helplessness or whether the offer of a thera-
peutic relationship is maintained throughout. It is very 
important that they experience the treating physician as 
a  reliable  source  of  information  and  a  professional 
counselor with whom they can discuss the indications 
and  decide  on  what  diagnostic  or  therapeutic  steps  to 
take next. Many patients are relieved simply to be told 
there is no somatic cause for their tinnitus and that their 
ear noise is essentially benign in nature, paving the way 
for the development of positive coping and habituation 
strategies.

Conflict of interest statement
Dr. Langguth has received consulting fees from ANM, Autifony, Merz, Novartis, 
and Sanofi, and lecture fees from Merz and ANM. He holds patents for the 
method of neuronavigational positioning of the TMS coil for treatment of 
 tinnitus and of treatment with cyclobenzaprine and naltrexone. Furthermore, 
he has received revenue from sales of the “Textbook of Tinnitus”.

Dr. Kreuzer has received third-party funding for study projects from Cerbomed 
GmbH. He has received reimbursement of congress attendance fees and 
travel costs from the Tinnitus Research Initiative. In addition, travel and 
 training costs have been paid on his behalf by Servier, Pfizer, AstraZeneca, 
Lilly, Bristol Myers Squibb, and Lundbeck.

Dr. Vielsmeier has received reimbursement of congress attendance fees and 
travel costs from the Tinnitus Research Initiative.

Manuscript received on 16 August 2012, revised version accepted on  
5 December 2012.

Translated from the original German by David Roseveare.

REFERENCES
1.  Eggermont JJ, Roberts LE: The neuroscience of tinnitus.  

Trends Neurosci 2004; 27: 676–82.

Deutsches Ärzteblatt International | Dtsch Arztebl Int 2013; 110(16): 278−84

M E D I C I N E

2. Hoffmann HJ, Reed G: Epidemiology of tinnitus. In: Snow JB 

(ed.): Tinnitus: Theory and Management. Hamilton: BC Decker 
2004; 6–41. 

3. Hebert S, Canlon B, Hasson D, Magnusson Hanson LL, 

 Westerlund H, Theorell T: Tinnitus severity is reduced with re-
duction of depressive mood-a prospective population study in 
Sweden. PLoS One 2012; 7: e37733.

4. Cima RF, Vlaeyen JW, Maes IH, Joore MA, Anteunis LJ: Tinnitus 
interferes with daily life activities: a psychometric examination 
of the Tinnitus Disability Index. Ear Hear 2011; 32: 623–33.

5. Javaheri S, Cohen V, Libman I, Sandor V: Life-threatening tinni-

tus. Lancet 2000; 356: 308.

6. Hall DA, Lainez MJ, Newman CW, Sanchez TG, Egler M, Tennig-
keit F, et al.: Treatment options for subjective tinnitus: self re-
ports from a sample of general practitioners and ENT physicians 
within Europe and the USA. BMC Health Serv Res 2011; 11: 
302.

7. Langguth B: Tinnitus: the end of therapeutic nihilism. Lancet 

2012; 379: 1926–8.

8. House JW, Brackmann DE: Tinnitus: surgical treatment. Ciba 

Found Symp 1981; 85: 204–16.

9. Norena AJ: An integrative model of tinnitus based on a central 

gain controlling neural sensitivity. Neurosci Biobehav Rev 2011; 
35: 1089–109.

10. Schaette R, Kempter R: Development of tinnitus-related neuron-
al hyperactivity through homeostatic plasticity after hearing loss: 
a computational model. Eur J Neurosci 2006; 23: 3124–38.

11. Yang S, Weiner BD, Zhang LS, Cho SJ, Bao S: Homeostatic 

 plasticity drives tinnitus perception in an animal model. Proc 
Natl Acad Sci U S A 2011; 108: 14974–9.

12. Vielsmeier V, Strutz J, Kleinjung T, Schecklmann M, Kreuzer PM, 
Landgrebe M, et al.: Temporomandibular joint disorder com-
plaints in tinnitus: further hints for a putative tinnitus subtype. 
PLoS One 2012; 7: e38887.

13. Schlee W, Weisz N, Bertrand O, Hartmann T, Elbert T: Using audi-
tory steady state responses to outline the functional connectivity 
in the tinnitus brain. PLoS One 2008; 3: e3720.

14. Schlee W, Mueller N, Hartmann T, Keil J, Lorenz I, Weisz N: 
 Mapping cortical hubs in tinnitus. BMC Biol 2009; 7: 80.

KEY MESSAGES 

● Chronic tinnitus is a common disorder in the general 
population; some patients suffer severe impairment of 
their quality of life.

● Following exclusion of treatable causes of the ear 
noise, management is symptomatic after careful as-
sessment of the indication depending on the  individual 
degree of bother.

● Treatment options include counseling, cognitive beha-

vioral therapy, and  various forms of auditory stimulation. 
Neuromodulatory techniques are in the early stages of 
development.

● The indication for pharmacological treatment of chronic 
tinnitus is currently  restricted to tinnitus-associated 
symptoms such as depressive mood, sleep disorders, 
and anxiety disorders.

● Because tinnitus has multiple possible causes and co-
morbidities, multidisciplinary diagnosis and treatment 
are of crucial importance. 

15. S1-Leitlinie der Deutschen Gesellschaft für Hals-Nasen-Ohren-
Heilkunde, Kopf- und Hals-Chirurgie (AWMF-Leitlinien-Register 
Nr. 017/064). www.awmf.org/leitlinien/detail/II/017-064.html 
(last accessed on 15 December 2012).

16. Heller MF, Bergman M: Tinnitus aurium in normally hearing 

 persons. Ann Otol Rhinol Laryngol 1953; 62: 73–83.

17. Folmer RL, Griest SE, Meikle MB, Martin WH: Tinnitus severity, 
loudness, and depression. Otolaryngol Head Neck Surg 1999; 
121: 48–51.

18. Schaette R, Turtle C, Munro KJ: Reversible induction of phantom 
auditory sensations through simulated unilateral hearing loss. 
PLoS One 2012; 7: e35238.

19. Hobson J, Chisholm E, El Refaie A: Sound therapy (masking) in 
the management of tinnitus in adults. Cochrane Database Syst 
Rev 2012; 11: CD006371.

20.  Hilton M, Stuart E: Ginkgo biloba for tinnitus. Cochrane Data -

base Syst Rev 2004: CD003852.

21. Baldo P, Doree C, Lazzarini R, Molin P, McFerran DJ: Antidepres-
sants for patients with tinnitus. Cochrane Database Syst Rev 
2006: CD003853.

22. Martinez-Devesa P, Perera R, Theodoulou M, Waddell A: 

 Cogni tive behavioural therapy for tinnitus. Cochrane Database 
Syst Rev 2010: CD005233.

23.  Phillips JS, McFerran D: Tinnitus retraining therapy (TRT) for 
 tinnitus. Cochrane Database Syst Rev 2010: CD007330.
24. Hoekstra CE, Rynja SP, van Zanten GA, Rovers MM: Anticonvul-

sants for tinnitus. Cochrane Database Syst Rev 2011: 
CD007960.

25. Meng Z, Liu S, Zheng Y, Phillips JS: Repetitive transcranial mag-
netic stimulation for tinnitus. Cochrane Database Syst Rev 
2011: CD007946.

26. Landgrebe M, Zeman F, Koller M, Eberl Y, Mohr M, Reiter J, et 
al.: The Tinnitus Research Initiative (TRI) database: a new ap-
proach for delineation of tinnitus subtypes and generation of 
predictors for treatment outcome. BMC Med Inform Decis Mak 
2010; 10: 42.

27. Langguth B, Goodey R, Azevedo A, Bjorne A, Cacace A, Crocetti 

A, et al.: Consensus for tinnitus patient assessment and 
 treatment outcome measurement: Tinnitus Research Initiative 
meeting, Regensburg, July 2006. Prog Brain Res 2007; 166: 
525–36.

28. Langguth B, Kleinjung T, Landgrebe M: Tinnitus: the complexity 

of standardization. Eval Health Prof 2011; 34: 429–33.

29. Newman CW, Sandridge SA: A comparison of benefit and eco -
nomic value between two sound therapy tinnitus management 
options. J Am Acad Audiol 2012; 23: 126–38.

30. Hoare DJ, Kowalkowski VL, Kang S, Hall DA: Systematic review 
and meta-analyses of randomized controlled trials examining 
tinnitus management. Laryngoscope 2011; 121: 1555–64.
31. Van de Heyning P, Vermeire K, Diebl M, Nopp P, Anderson I, De 
Ridder D: Incapacitating unilateral tinnitus in single-sided deaf-
ness treated by cochlear implantation. Ann Otol Rhinol Laryngol 
2008; 117: 645–52.

32. Bauer CA, Brozoski TJ: Effect of tinnitus retraining therapy on 
the loudness and annoyance of tinnitus: a controlled trial. Ear 
Hear 2011; 32: 145–55.

33. Dohrmann K, Weisz N, Schlee W, Hartmann T, Elbert T: Neurofeed-
back for treating tinnitus. Prog Brain Res 2007; 166: 473–85.
34. Peng Z, Chen XQ, Gong SS: Effectiveness of repetitive trans -

cranial magnetic stimulation for chronic tinnitus: a systematic 
Review. Otolaryngol Head Neck Surg 2012; 147: 817–25.
35. Plewnia C: Brain stimulation: new vistas for the exploration and 
treatment of tinnitus. CNS Neurosci Ther 2011; 17: 449–61.
36. Davis PB, Paki B, Hanley PJ: Neuromonics tinnitus treatment: 

third clinical trial. Ear Hear 2007; 28: 242–59.

Deutsches Ärzteblatt International | Dtsch Arztebl Int 2013; 110(16): 278−84 

283

M E D I C I N E

37.  Okamoto H, Stracke H, Stoll W, Pantev C: Listening to tailor-
 made notched music reduces tinnitus loudness and tinnitus-
 related auditory cortex activity. Proc Natl Acad Sci USA 2010; 
107: 1207–10.

38. Tass PA, Adamchic I, Freund HJ, von Stackelberg T, Hauptmann 
C: Counteracting tinnitus by acoustic coordinated reset neuro -
modulation. Restor Neurol Neurosci 2012; 2: 137–9.

39. Elgoyhen AB, Langguth B: Pharmacological approaches to the 
treatment of tinnitus. Drug Discov Today 2010; 15: 300–5.
40. Cima RF, Maes IH, Joore MA, Scheyen DJ, El Refaie A, Baguley 
DM, et al.: Specialised treatment based on cognitive behaviour 
therapy versus usual care for tinnitus: a randomised controlled 
trial. Lancet 2012; 379: 1951–9.

Corresponding author 
Dr. med. Peter M. Kreuzer     
Universitätsstr. 84, 93053 Regensburg, Germany 
peter.kreuzer@medbo.de 

@ For eReferences please refer to: 

www.aerzteblatt-international.de/ref1613

284 

Deutsches Ärzteblatt International | Dtsch Arztebl Int 2013; 110(16): 278−84

M E D I C I N E

REVIEW ARTICLE

Chronic Tinnitus:  
an Interdisciplinary Challenge

Peter M. Kreuzer, Veronika Vielsmeier, Berthold Langguth

eReferences

e1. Gopinath B, McMahon CM, Rochtchina E, Karpa MJ, Mitchell P: 
Incidence, persistence, and progression of tinnitus symptoms in 
older adults: the Blue Mountains Hearing Study. Ear Hear 2010; 
31: 407–12.

e2.

e3.

e4.

e5.

e6.

e7.

e8.

e9.

 Zeng C, Nannapaneni N, Zhou J, Hughes LF, Shore S: Cochlear 
damage changes the distribution of vesicular glutamate trans-
porters associated with auditory and nonauditory inputs to the 
cochlear nucleus. J Neurosci 2009; 29: 4210–7.

 Zeng C, Yang Z, Shreve L, Bledsoe S, Shore S: Somatosensory 
projections to cochlear nucleus are upregulated after unilateral 
deafness. J Neurosci 2012; 32: 15791–801.

 Shore SE: Plasticity of somatosensory inputs to the cochlear 
 nucleus-implications for tinnitus. Hear Res 2011; 281: 38–46.

 Levine RA: Somatic (craniocervical) tinnitus and the dorsal coch-
lear nucleus hypothesis. Am J Otolaryngol 1999; 20: 351–62.

 Sanchez TG, Rocha CB: Diagnosis and management of somato-
sensory tinnitus: review article. Clinics (Sao Paulo) 2011; 66: 
1089–94.

 Adjamian P, Sereda M, Hall DA: The mechanisms of tinnitus: per-
spectives from human functional neuroimaging. Hear Res 2009; 
253: 15–31.

 Lanting CP, de Kleine E, van Dijk P: Neural activity underlying 
 tinnitus generation: results from PET and fMRI. Hear Res 2009; 
255: 1–13.

 Landgrebe M, Barta W, Rosengarth K, Frick U, Hauser S, Lang-
guth B, et al.: Neuronal correlates of symptom formation in func-
tional somatic syndromes: a fMRI study. Neuroimage 2008; 41: 
1336–44.

e10. Tyler R, Coelho C, Tao P, Ji H, Noble W, Gehringer A, et al.: Iden-

tifying tinnitus subgroups with cluster analysis. Am J Audiol 2008; 
17: 176–84.

e11. Häuser W, Hansen E, Enck P: Nocebo phenomena in medicine: 

their relevance in everyday clinical practice. Dtsch Arztebl Int 
2012; 109(26): 459–65.

e12. Searchfield G, Magnusson J, Shakes G, Biesinger E, Kong O: 

e15. Melin L, Scott B, Lindberg P, Lyttkens L: Hearing aids and tinni-
tus—an experimental group study. Br J Audiol 1987; 21: 91–7.

e16. Schaette R, Konig O, Hornig D, Gross M, Kempter R: Acoustic 
stimulation treatments against tinnitus could be most effective 
when tinnitus pitch is within the stimulated frequency range. Hear 
Res 2010; 269: 95–101.

e17.

e18.

e19.

 Olze H, Zahnert T, Hesse G: Hörgeräte, implantierbare Hörgeräte 
und Cochlear Implants in der Therapie des chronischen Tinnitus. 
HNO 2010; 58: 1004–12. 

 Kompis M, Pelizzone M, Dillier N, Allum J, DeMin N, Senn P: 
 Tinnitus before and 6 months after cochlear implantation. Audiol 
Neurootol 2012; 17: 161–8.

 Flor H, Hoffmann D, Struve M, Diesch E: Auditory discrimination 
training for the treatment of tinnitus. Appl Psychophysiol Biofeed-
back 2004; 29: 113–20.

e20. Herraiz C, Diges I, Cobo P: Auditory discrimination therapy (ADT) 

for tinnitus management. Prog Brain Res 2007; 166: 467–71.

e21. Roberts LE, Bosnyak DJ: Auditory training in tinnitus. In: Moller A, 

et al. (eds.): Textbook of tinnitus. 1 edition. New York: Springer 
2011; 563–73.

e22. Searchfield GD, Morrison-Low J, Wise K: Object identification and 
attention training for treating tinnitus. Prog Brain Res 2007; 166: 
441–60.

e23. Henry JA, Schechter MA, Zaugg TL, Griest S, Jastreboff PJ, Ver-
non JA, et al.: Outcomes of clinical trial: tinnitus masking versus 
tinnitus retraining therapy. J Am Acad Audiol 2006; 17: 104–32.

e24. Herraiz C, Hernandez FJ, Plaza G, de los Santos G: Long-term 

 clinical trial of tinnitus retraining therapy. Otolaryngol Head Neck 
Surg 2005; 133: 774–9.

e25. Crocetti A, Forti S, Del Bo L: Neurofeedback for subjective tinnitus 

patients. Auris Nasus Larynx 2011; 38: 735–8.

e26.

e27.

 Gosepath K, Nafe B, Ziegler E, Mann WJ: Neurofeedback in der 
Therapie des Tinnitus. HNO 2001; 49: 29–35. 

Israel JM, Connelly JS, McTigue ST, Brummett RE, Brown J: Lido-
caine in the treatment of tinnitus aurium. A double-blind study. 
Arch Otolaryngol 1982; 108: 471–3.

Counceling and psycho-education for tinnitus management. In: 
Moller A, Langguth B, de Ridder D, Kleinjung T (eds): Textbook of 
tinnitus. 1st edition. Springer 2011: 535–6.

e28. Melding PS, Goodey RJ, Thorne PR: The use of intravenous ligno-
caine in the diagnosis and treatment of tinnitus. J Laryngol Otol 
1978; 92: 115–21.

e13. Zenner HP, Pfister M, Birbaumer N: Tinnitus sensitization: Sensory 

e29. Langguth B, Biesinger E, Del Bo L, De Ridder D, Goodey R, 

and psychophysiological aspects of a new pathway of acquired 
centralization of chronic tinnitus. Otol Neurotol 2006; 27: 
1054–63.

 Herraiz C, et al.: Algorithm for the diagnostic and therapeutic 
management of tinnitus. In: Moller A, Langguth B, de Ridder D, 
Kleinjung T (eds): Textbook of tinnitus. 1st edition. Springer 2011. 

e14.

 Tyler RS, Noble W, Coelho CB, Ji H: Tinnitus retraining therapy: 
mixing point and total masking are equally effective. Ear Hear 
2012; 33: 588–94.

e30. Biesinger E, Heiden C, Greimel V, Lendle T, Hoing R, Albegger K: 
Strategien in der ambulanten Behandlung des Tinnitus. HNO 
1998; 46: 157–69. 

Deutsches Ärzteblatt International | Dtsch Arztebl Int 2013; 110(16) | Kreuzer et al.: eReferences 

I
